| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 109 | 1.092 | 114 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 5.086 | 0 | 0 | 2.127 | 11.750 | 6.330 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 9.288 | 4.174 | 6.074 | 8.151 | 18.561 | 11.778 | 3.141 | 2.464 | 3.552 | 3.537 |
| Gross Profit/Loss - EUR | -4.202 | -4.174 | -6.074 | -6.024 | -6.811 | -5.447 | -3.141 | -2.464 | -3.552 | -3.537 |
| Net Profit/Loss - EUR | -4.202 | -4.174 | -6.074 | -6.025 | -6.822 | -5.449 | -3.141 | -2.464 | -3.552 | -3.537 |
| Employees | 0 | 0 | 0 | 2 | 3 | 1 | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Avil Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 5.108 | 6.421 | 6.933 | 6.805 | 6.474 | 6.157 | 5.829 | 5.847 | 4.965 | 20 |
| Current Assets | 110 | 101 | 43 | 2.077 | 2.238 | 123 | 95 | 45 | 4 | 252 |
| Inventories | 0 | 0 | 0 | 0 | 21 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 1.934 | 1.956 | 0 | 0 | 0 | 0 | 0 |
| Cash | 110 | 101 | 43 | 143 | 261 | 123 | 95 | 45 | 4 | 252 |
| Shareholders Funds | -9.984 | -14.057 | -19.893 | -25.553 | -31.880 | -36.725 | -39.051 | -41.636 | -45.061 | -48.346 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 15.203 | 20.578 | 26.869 | 34.436 | 40.593 | 43.004 | 44.975 | 47.528 | 50.030 | 53.535 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Avil Med S.r.l.